Your English writing platform
Discover LudwigExact(6)
Safety will be evaluated by reporting adverse events; side effects and QoL using validated questionnaires.
The immunogenicity persistence and vaccine safety will be evaluated up to 10 years after the first dose.
Safety will be evaluated by tabulating and reporting the distribution of the worst grade of each type of toxicity found, per patient, separately by treatment.
Patient safety will be evaluated by recording the number of adverse and serious adverse events which occur during the study period (see safety procedures).
Efficacy will be evaluated every 56 days (2 cycles), whereas safety will be evaluated every 28 days (1 cycle) for the first 8 months and every 56 days thereafter.
Patients who persist in noncompliance will be contact though telephone or internet survey for self-report outcome measures Although considerable previous observational work suggest that both procedures are safe [ 21, 26, 28, 30, 32, 83- 86], safety will be evaluated by an external committee (DSMB) in conjunction with the steering committee (who will retain executive power).
Similar(54)
Finally, key safety considerations will be evaluated with a subpopulation with optical coherence tomography imaging for strut coverage, late strut malapposition, and plaque volume, as well as serial human antimurine antibody assessments.
At 6 weeks after inclusion of these patients the trial's safety data will be evaluated.
The safety outcome will be evaluated by measuring the time to first occurrence of any major bleeding event.
Serious adverse events (SAEs) are of high interest and are a key part of comparative safety that will be evaluated within CERTAIN.
Finally, safety data will be evaluated by comparing incidences (number and % of subjects with at least one occurrence) of key SAEs and SUSARs between both groups (e.g. hospitalisations).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com